Ascent Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
6,363
+77
+1% +$16K 0.05% 312
2026
Q1
$1.33M Buy
6,286
+811
+15% +$175K 0.05% 314
2025
Q4
$1.12M Buy
5,475
+41
+0.8% +$7.72K 0.04% 343
2025
Q3
$853K Sell
5,434
-1,166
-18% -$180K 0.03% 391
2025
Q2
$1.11M Buy
6,600
+2,491
+61% +$370K 0.04% 315
2025
Q1
$566K Buy
4,109
+137
+3% +$17.5K 0.02% 437
2024
Q4
$470K Sell
3,972
-10
-0.3% -$1.17K 0.04% 385
2024
Q3
$440K Sell
3,982
-193
-5% -$20.2K 0.03% 391
2024
Q2
$410K Sell
4,175
-406
-9% -$41.4K 0.03% 382
2024
Q1
$513K Sell
4,581
-181
-4% -$19.5K 0.05% 351
2023
Q4
$493K Buy
4,762
+56
+1% +$5.56K 0.05% 348
2023
Q3
$484K Buy
4,706
+338
+8% +$30.6K 0.05% 317
2023
Q2
$401K Buy
4,368
+1,059
+32% +$89.5K 0.04% 340
2023
Q1
$250K Sell
3,309
-2,594
-44% -$196K 0.03% 428
2022
Q4
$454K Buy
5,903
+746
+14% +$56.7K 0.05% 314
2022
Q3
$391K Buy
+5,157
New +$327K 0.05% 328

Other funds holding CAH

Ascent Group's CAH Position: Q2 2026 in Review

Ascent Group increased its Cardinal Health (CAH) stake by 1.2% in Q2 2026, buying an estimated $16K and bringing the position to 6,363 shares worth $1.51M. The position accounts for 0.05% of the portfolio, ranked #312.

Ascent Group first reported a position in CAH in Q3 2022 and has held it in 16 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Ascent Group held 6,363 shares of Cardinal Health worth $1.51M as of Q2 2026.
  • Ascent Group bought 77 Cardinal Health shares in Q2 2026, an estimated $16K.
  • Cardinal Health made up 0.05% of Ascent Group's portfolio in Q2 2026, its #312 holding.
  • Ascent Group first reported a position in Cardinal Health in Q3 2022 and has held it in 16 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.